Cerebral Amyloid Angiopathy Latest Advances
Find the Latest Research About Cerebral Amyloid Angiopathy
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3468 publications
Carbonic anhydrase inhibition rescues heart function in the Tg2576 Alzheimer's mouse model by ameliorating cardiac amyloid-β pathology and neurotrophic-signaling impairment.
Journal: bioRxiv : the preprint server for biology
Published: October 25, 2026
Generalizing Amyloid β Pathology from Postmortem Human Brains with Vision Foundation Models for Lesion Quantification.
Journal: medRxiv : the preprint server for health sciences
Published: October 25, 2026
Cerebral Amyloid Angiopathy Caused by Immunoglobulin Light Chain Amyloidosis.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: October 15, 2026
Digital quantification of vascular β-amyloid and perivascular plaques in cerebral amyloid angiopathy.
Journal: Research square
Published: October 08, 2026
HIGH-DIMENSIONAL MULTI-OMIC MAPPING OF POST-MORTEM HUMAN BRAIN USING ITERATIVE INDIRECT IMMUNOFLUORESCENCE IMAGING ON XENIUM-PROCESSED TISSUES.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Characterization of the knock-in App SAA mouse model as a powerful tool for Alzheimer's disease preclinical research.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
High-Dimensional Multi-Omic Mapping of Post-Mortem Human Brain Using Iterative Indirect Immunofluorescence Imaging on Xenium-Processed Tissues.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2026
Disease Progression in Iatrogenic Cerebral Amyloid Angiopathy.
Journal: Neurology
Published: September 29, 2026
Correction to: Long-Term Blood Pressure Variability in Cerebral Amyloid Angiopathy Is Associated With Ischemic Brain Injury and Cognitive Decline.
Journal: Journal of the American Heart Association
Published: September 25, 2026
Semaphorin 3G (SEMA3G) is a highly selective marker of cerebral amyloid angiopathy.
Journal: bioRxiv : the preprint server for biology
Published: September 24, 2026
Last Updated: 11/08/2026